Published in J Cereb Blood Flow Metab on November 01, 2003
Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye. Cytokine (2013) 0.89
Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells. Sci Rep (2015) 0.78
Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J Neural Transm (Vienna) (2008) 0.76
Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care (2007) 2.29
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest (2004) 1.92
The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp Gerontol (2006) 1.82
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation. J Hepatol (2002) 1.76
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging (2009) 1.76
Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care (2013) 1.71
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care (2011) 1.70
Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol (2004) 1.55
Alzheimer vaccine: amyloid-beta on trial. Bioessays (2003) 1.43
The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care (2003) 1.42
Antioxidant and anti-inflammatory activities of selected Chinese medicinal plants and their relation with antioxidant content. BMC Complement Altern Med (2012) 1.38
Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles? Mutat Res (2009) 1.28
Activation of tubular epithelial cells in diabetic nephropathy. Diabetes (2002) 1.24
Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds. J Agric Food Chem (2011) 1.18
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Deliv Rev (2008) 1.18
Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex (2004) 1.14
Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 1.12
Advanced glycation end products and mortality in hemodialysis patients. Kidney Int (2002) 1.12
Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells--protection by carbonyl scavengers. Neurobiol Aging (2006) 1.08
Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res (2002) 1.08
Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J Neurochem (2005) 1.08
Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Anal Biochem (2005) 1.08
Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging (2006) 1.05
Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study. Atherosclerosis (2008) 1.04
Monitoring of clopidogrel action: comparison of methods. Clin Chem (2005) 1.04
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther (2006) 1.01
Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease? Exp Gerontol (2010) 0.99
A quick, convenient and economical method for the reliable determination of methylglyoxal in millimolar concentrations: the N-acetyl-L-cysteine assay. Anal Bioanal Chem (2012) 0.98
Activated astrocytes: a therapeutic target in Alzheimer's disease? Expert Rev Neurother (2009) 0.94
Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J Neurochem (2003) 0.93
A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study. Atherosclerosis (2007) 0.93
Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem (2006) 0.92
Methylglyoxal, cognitive function and cerebral atrophy in older people. J Gerontol A Biol Sci Med Sci (2012) 0.92
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model. Am J Kidney Dis (2003) 0.91
Genotoxicity of advanced glycation end products in mammalian cells. Cancer Lett (2003) 0.91
Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line. Eur J Neurosci (2003) 0.90
Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. J Neurosci Res (2006) 0.90
Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Ann N Y Acad Sci (2008) 0.90
Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease. Clin Chem Lab Med (2011) 0.89
Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts. Mol Nutr Food Res (2010) 0.88
Lessons from the AN 1792 Alzheimer vaccine: lest we forget. Neurobiol Aging (2004) 0.87
Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity. Free Radic Biol Med (2005) 0.87
Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci (2005) 0.86
Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging (2005) 0.85
Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox Biol (2013) 0.85
Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.85
Optimizing the generation of stable neuronal cell lines via pre-transfection restriction enzyme digestion of plasmid DNA. Cytotechnology (2010) 0.84
Cytoprotective properties of traditional Chinese medicinal herbal extracts in hydrogen peroxide challenged human U373 astroglia cells. Neurochem Int (2012) 0.84
Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells. Cell Mol Neurobiol (2012) 0.84
Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4. Mutagenesis (2012) 0.83
The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox Res (2005) 0.83
The novel nitric oxide synthase inhibitor 4-amino-tetrahydro-L-biopterine prevents brain edema formation and intracranial hypertension following traumatic brain injury in mice. J Neurotrauma (2009) 0.83
Endothelial nitric oxide synthase mediates arteriolar vasodilatation after traumatic brain injury in mice. J Neurotrauma (2015) 0.83
Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages. Mol Nutr Food Res (2008) 0.83
Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors. Ann N Y Acad Sci (2005) 0.82
Automated quantification of neurite outgrowth orientation distributions on patterned surfaces. J Neural Eng (2014) 0.82
Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine (2007) 0.81
Aldosterone increases kidney tubule cell oxidants through calcium-mediated activation of NADPH oxidase and nitric oxide synthase. Free Radic Biol Med (2011) 0.81
Development of a high-performance liquid chromatography method for the simultaneous quantitation of glutathione and related thiols. Anal Biochem (2012) 0.81
Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures. Biochim Biophys Acta (2006) 0.80
Bacopa monnieri (L.) exerts anti-inflammatory effects on cells of the innate immune system in vitro. Food Funct (2014) 0.80
Advanced glycation end product accumulation in rho(0) cells without a functional respiratory chain. Biol Chem (2009) 0.80
Maillard reaction products enriched food extract reduce the expression of myofibroblast phenotype markers. Mol Nutr Food Res (2007) 0.80
The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase. Rejuvenation Res (2011) 0.79
Coffee and Maillard products activate NF-kappaB in macrophages via H2O2 production. Mol Nutr Food Res (2007) 0.79
A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and neuroprotective compounds. J Alzheimers Dis (2010) 0.79
A protein phosphorylation-based assay for screening and monitoring of drugs modulating cyclic nucleotide pathways. Anal Biochem (2010) 0.79
Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y. J Alzheimers Dis (2003) 0.78
Increased protein glycation in cirrhosis and therapeutic strategies to prevent it. Ann N Y Acad Sci (2005) 0.78
Determination of anti-inflammatory activities of standardised preparations of plant- and mushroom-based foods. Eur J Nutr (2013) 0.78
Vitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic mice. PLoS One (2013) 0.78
Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts. Toxicol In Vitro (2007) 0.78
Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality. Nephrol Dial Transplant (2002) 0.78
Neuroprotective therapies for Alzheimer's disease. Curr Pharm Des (2006) 0.78
Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells. Neurotox Res (2006) 0.78
Nitric oxide synthase inhibition with the antipterin VAS203 improves outcome in moderate and severe traumatic brain injury: a placebo-controlled randomized Phase IIa trial (NOSTRA). J Neurotrauma (2014) 0.77
Activation of the transcription factor Nrf2 in macrophages, Caco-2 cells and intact human gut tissue by Maillard reaction products and coffee. Amino Acids (2012) 0.77
Functional hyperhomocysteinemia in healthy vegetarians: no association with advanced glycation end products, markers of protein oxidation, or lipid peroxidation after correction with vitamin B(12). Clin Chem (2003) 0.77
Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts - identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds. Food Funct (2015) 0.77
Proenergetic effects of resveratrol in the murine neuronal cell line Neuro2a. Mol Nutr Food Res (2013) 0.77
Generation of hydrogen peroxide-resistant murine neuroblastoma cells: a target discovery platform for novel neuroprotective genes. J Neural Transm (Vienna) (2013) 0.77
Proteins of Thermus thermophilus are resistant to glycation-induced protein precipitation: an evolutionary adaptation to life at extreme temperatures? Ann N Y Acad Sci (2005) 0.76
Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages. Food Chem (2013) 0.76
Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J Neural Transm (Vienna) (2008) 0.76
Cytotoxicity of Maillard reaction products determined with a peptide spot library. Mol Nutr Food Res (2009) 0.76
Identification of hydrogen peroxide as a major cytotoxic component in Maillard reaction mixtures and coffee. Mol Nutr Food Res (2009) 0.76
Nuclear translocation of NF-κB in intact human gut tissue upon stimulation with coffee and roasting products. Food Funct (2011) 0.76
Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts". Neurobiol Aging (2005) 0.75
Comment on Vicki Brower's article 'Harnessing the immune system to battle Alzheimer's' in EMBO reports, March 2002. EMBO Rep (2002) 0.75
Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study. Australas Psychiatry (2013) 0.75
Two analytical methods to study the interaction of AGEs with cell surface proteins. J Biochem Biophys Methods (2005) 0.75
Characterization of antibody affinities using an AGE-modified dipeptide spot library. J Immunol Methods (2002) 0.75